Παρακολούθηση
Taehyong Kim
Taehyong Kim
Director of Bioinformatics Core, University of Pennsylvania
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα upenn.edu - Αρχική σελίδα
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised …
C Eng, TW Kim, J Bendell, G Argilés, NC Tebbutt, M Di Bartolomeo, ...
The lancet oncology 20 (6), 849-861, 2019
5032019
Genome-wide prediction of metabolic enzymes, pathways, and gene clusters in plants
P Schläpfer, P Zhang, C Wang, T Kim, M Banf, L Chae, K Dreher, ...
Plant physiology 173 (4), 2041-2059, 2017
3692017
Genomic signatures of specialized metabolism in plants
L Chae, T Kim, R Nilo-Poyanco, SY Rhee
Science 344 (6183), 510-513, 2014
2992014
Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint …
CS Anderson, Y Huang, RI Lindley, X Chen, H Arima, G Chen, Q Li, ...
The Lancet 393 (10174), 877-888, 2019
2632019
Choi
HK Kim, E Wilson
H., & Verpoorte, 1094-1102, 2010
1522010
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic …
YH Park, TY Kim, GM Kim, SY Kang, IH Park, JH Kim, KE Lee, HK Ahn, ...
The Lancet Oncology 20 (12), 1750-1759, 2019
1192019
Bridging centrality: graph mining from element level to group level
W Hwang, T Kim, M Ramanathan, A Zhang
Proceedings of the 14th ACM SIGKDD international conference on Knowledge …, 2008
1152008
Efficacy and safety results from IMblaze370, a randomised Phase III study comparing atezolizumab+ cobimetinib and atezolizumab monotherapy vs regorafenib in chemotherapy …
J Bendell, F Ciardiello, J Tabernero, N Tebbutt, C Eng, M Di Bartolomeo, ...
Annals of Oncology 29, v123, 2018
702018
Automatic segmentation of the spinal cord and the dural sac in lumbar MR images using gradient vector flow field
J Koh, T Kim, V Chaudhary, G Dhillon
2010 Annual International Conference of the IEEE Engineering in Medicine and …, 2010
642010
Angiotensin-converting enzyme gene polymorphism and vascular manifestations in Korean patients with SLE
WS Uhm, HS Lee, YH Chung, TH Kim, SC Bae, KB Joo, TY Kim, DH Yoo
Lupus 11 (4), 227-233, 2002
642002
Measuring semantic similarities by combining gene ontology annotations and gene co-function networks
J Peng, S Uygun, T Kim, Y Wang, SY Rhee, J Chen
BMC bioinformatics 16, 1-14, 2015
522015
A multi-institutional study of the prevalence of BRCA1 and BRCA2 large genomic rearrangements in familial breast cancer patients
MW Seong, SI Cho, KH Kim, IY Chung, E Kang, JW Lee, SK Park, MH Lee, ...
BMC cancer 14, 1-6, 2014
442014
Randomized phase II study of nimotuzumab, an anti-EGFR antibody, plus irinotecan in patients with 5-fluorouracil–based regimen-refractory advanced or recurrent gastric cancer …
YH Kim, Y Sasaki, KH Lee, SY Rha, S Park, N Boku, Y Komatsu, T Kim, ...
Journal of Clinical Oncology 29 (4_suppl), 87-87, 2011
372011
Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic …
YH Park, SA Im, SB Kim, JH Sohn, KS Lee, YS Chae, KH Lee, JH Kim, ...
European Journal of Cancer 86, 385-393, 2017
322017
Patterns of metabolite changes identified from large-scale gene perturbations in Arabidopsis using a genome-scale metabolic network
T Kim, K Dreher, R Nilo-Poyanco, I Lee, O Fiehn, BM Lange, BJ Nikolau, ...
Plant physiology 167 (4), 1685-1698, 2015
272015
Continuous suspended cell culture of Mentha piperita in cell-recycled air-lift bioreactor
IS Chung, YM Kang, JH Oh, T Kim, HJ Lee, YA Chae
Biotechnology techniques 8, 789-792, 1994
231994
Spatial modeling of bone microarchitecture
H Li, K Li, T Kim, A Zhang, M Ramanathan
Three-Dimensional Image Processing (3DIP) and Applications II 8290, 232-240, 2012
212012
Phase I study of everolimus in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC).
RS Finn, RTP Poon, T Yau, H Klumpen, L Chen, Y Kang, T Kim, ...
Journal of Clinical Oncology 29 (15_suppl), 4074-4074, 2011
212011
Factors influencing performance of hard rock tunnel boring machines
S Yagiz, J Rostami, T Kim, L Ozdemir, C Merguerian
ISRM EUROCK, ISRM-EUROCK-2009-112, 2009
202009
ACS Sustainable Chem
Y Myung, S Jung, TT Tung, KM Tripathi, T Kim
Eng 7, 3772-3782, 2019
192019
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20